1,378
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism

, , , , &
Pages 1-15 | Received 13 Oct 2017, Accepted 08 Jan 2018, Published online: 21 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Suchada Niamsuphap, Christian Fercher, Sumukh Kumble, Pie Huda, Stephen M Mahler & Christopher B Howard. (2020) Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets. Expert Opinion on Drug Delivery 17:9, pages 1189-1211.
Read now
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, Maryam Dadar, Yashpal Singh Malik, Karam Pal Singh & Wanpen Chaicumpa. (2020) COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics 16:6, pages 1232-1238.
Read now

Articles from other publishers (27)

Jing Yi Lai, Angela Corona, Chong Lee Ng, Enzo Tramontano, Yee Siew Choong & Theam Soon Lim. (2023) Naïve antibody library derived monoclonal antibody against VP35 of Ebola virus. International Journal of Biological Macromolecules 245, pages 125571.
Crossref
Thanida Chanpong, Watee Seesuay, Wararat Chiangjong, Piamsiri Jiramornimit, Sarinthip Preedagasamzin, Korakot Atjanasuppat, Bunyada Jittorntrum, Somsak Prasongtanakij, Supannikar Tawinwung, Sulada Pukiat, Chonticha Saisawang, Suparerk Borwornpinyo, Khanit Sa-ngiamsuntorn, Wanpen Chaichumpa, Suradej Hongeng & Usanarat Anurathapan. (2023) A novel anti-membrane CD30 single-chain variable fragment discovered from the human phage library: A potential targeted immunotherapy. PLOS ONE 18:4, pages e0284708.
Crossref
Kittirat Glab-ampai, Kanasap Kaewchim, Thanatsaran Saenlom, Watayagorn Thepsawat, Kodchakorn Mahasongkram, Nitat Sookrung, Wanpen Chaicumpa & Monrat Chulanetra. (2022) Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants. International Journal of Molecular Sciences 23:12, pages 6587.
Crossref
Issa Sadeghian, Reza Heidari, Sara Sadeghian, Mohammad Javad Raee & Manica Negahdaripour. (2022) Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. European Journal of Pharmaceutical Sciences 169, pages 106094.
Crossref
Angela Corona, Elisa Fanunza, Cristiano Salata, Melody Jane Morwitzer, Simona Distinto, Luca Zinzula, Cinzia Sanna, Aldo Frau, Gian Luca Daino, Marina Quartu, Orazio Taglialatela-Scafati, Daniela Rigano, StPatrick Reid, Alì Mirazimi & Enzo Tramontano. (2022) Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production. Antiviral Research 198, pages 105251.
Crossref
Louis K. S. Darko, Emmanuel Broni, Dominic S. Y. Amuzu, Michael D. Wilson, Christian S. Parry & Samuel K. Kwofie. (2021) Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds. Biomedicines 9:12, pages 1796.
Crossref
Mykola Lisianyi. (2021) ОСОБЛИВОСТІ ГУМОРАЛЬНОГО ІМУНІТЕТУ ПРИ COVID-19 ТА ПЕРСПЕКТИВИ ВИКОРИСТАННЯ ПРОТИВІРУСНИХ АНТИТІЛ В КЛІНІЧНІЙ ПРАКТИЦІ (ОГЛЯД ЛІТЕРАТУРИ). Immunology and Allergology: Science and Practice:3, pages 14-22.
Crossref
Ariel S. Wirchnianski, Anna Z. Wec, Elisabeth K. Nyakatura, Andrew S. Herbert, Megan M. Slough, Ana I. Kuehne, Eva Mittler, Rohit K. Jangra, Jonathan Teruya, John M. Dye, Jonathan R. Lai & Kartik Chandran. (2021) Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity. Frontiers in Immunology 12.
Crossref
Pravas Kumar Baral, Jiang Yin & Michael N.G. James. (2021) Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. International Journal of Biological Macromolecules 186, pages 490-500.
Crossref
Kristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, Stephan Steinke, Nora Langreder, Philip Alexander Heine, Kai-Thomas Schneider, Rico Ballmann, Viola Fühner, Philipp Kuhn, Thomas Schirrmann, André Frenzel, Stefan Dübel, Maren Schubert, Gustavo Marçal Schmidt Garcia Moreira, Federico Bertoglio, Giulio Russo & Michael Hust. (2021) Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Jizong Jiang. (2021) Cell-penetrating Peptide-mediated Nanovaccine Delivery. Current Drug Targets 22:8, pages 896-912.
Crossref
Mai H.S. Mohammad. (2021) Immune response scenario and vaccine development for SARS-CoV-2 infection. International Immunopharmacology 94, pages 107439.
Crossref
Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh & Bismita Nayak. (2021) A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. Frontiers in Pharmacology 11.
Crossref
Anna Laura Paulis, Angela Corona & Enzo Tramontano. 2021. Coronaviruses and other Novel Antiviral Targets. Coronaviruses and other Novel Antiviral Targets 153 174 .
Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey & Thakur Prasad Yadav. (2020) Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review. Journal of Medical Virology 93:1, pages 275-299.
Crossref
Zainab Sarwar, Tahir Ahmad & Salik Kakar. (2020) Potential approaches to combat COVID-19: a mini-review. Molecular Biology Reports 47:12, pages 9939-9949.
Crossref
Hajar Owji, Manica Negahdaripour & Nasim Hajighahramani. (2020) Immunotherapeutic approaches to curtail COVID-19. International Immunopharmacology 88, pages 106924.
Crossref
Kuldeep Dhama, Sharun Khan, Ruchi Tiwari, Shubhankar Sircar, Sudipta Bhat, Yashpal Singh Malik, Karam Pal Singh, Wanpen Chaicumpa, D. Katterine Bonilla-Aldana & Alfonso J. Rodriguez-Morales. (2020) Coronavirus Disease 2019–COVID-19. Clinical Microbiology Reviews 33:4.
Crossref
Hossein Hozhabri, Francesca Piceci Sparascio, Hamidreza Sohrabi, Leila Mousavifar, René Roy, Daniela Scribano, Alessandro De Luca, Cecilia Ambrosi & Meysam Sarshar. (2020) The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting. International Journal of Environmental Research and Public Health 17:16, pages 5648.
Crossref
Alessandra Fierabracci, Andrea Arena & Paolo Rossi. (2020) COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis. International Journal of Molecular Sciences 21:14, pages 5145.
Crossref
Elisa Fanunza, Aldo Frau, Angela Corona & Enzo Tramontano. (2019) Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets. Infectious Disorders - Drug Targets 19:4, pages 362-374.
Crossref
Michela Flego, Aldo Frau, Luisa Accardi, Alessandra Mallano, Alessandro Ascione, Mara Gellini, Elisa Fanunza, Stefano Vella, Paola Di Bonito & Enzo Tramontano. (2019) Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity. BMC Biotechnology 19:1.
Crossref
Parmeshwar Amatya, Nicole Wagner, Gang Chen, Priya Luthra, Liuqing Shi, Dominika Borek, Alevtina Pavlenco, Henry Rohrs, Christopher F. Basler, Sachdev S. Sidhu, Michael L. Gross & Daisy W. Leung. (2019) Inhibition of Marburg Virus RNA Synthesis by a Synthetic Anti-VP35 Antibody. ACS Infectious Diseases 5:8, pages 1385-1396.
Crossref
Francesco Di Palma, Gian Luca Daino, Venkata Krishnan Ramaswamy, Angela Corona, Aldo Frau, Elisa Fanunza, Attilio V Vargiu, Enzo Tramontano & Paolo Ruggerone. (2019) Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition. Antiviral Chemistry and Chemotherapy 27, pages 204020661988922.
Crossref
Sandeep Sharma & Jeena Gupta. 2019. Pathogenicity and Drug Resistance of Human Pathogens. Pathogenicity and Drug Resistance of Human Pathogens 251 282 .
Tatiana A. Slastnikova, A. V. Ulasov, A. A. Rosenkranz & A. S. Sobolev. (2018) Targeted Intracellular Delivery of Antibodies: The State of the Art. Frontiers in Pharmacology 9.
Crossref
Kuldeep Dhama, Kumaragurubaran Karthik, Rekha Khandia, Sandip Chakraborty, Ashok Munjal, Shyma K. Latheef, Deepak Kumar, Muthannan Andavar Ramakrishnan, Yashpal Singh Malik, Rajendra Singh, Satya Veer Singh Malik, Raj Kumar Singh & Wanpen Chaicumpa. (2018) Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus. Frontiers in Immunology 9.
Crossref